Murphy, Lynch Introduce Bipartisan Resolution for AADC Deficiency Awareness Day
WASHINGTON, D.C. — Today, Rep. Greg Murphy, M.D. (NC-03) introduced a bipartisan resolution with Rep. Stephen Lynch (D-MA) to designate October 23, 2021 as AADC Deficiency Awareness Day. AADC Deficiency is a genetic neurologic rare disease that affects approximately 1 in 100,000 people in the United States.
“I am proud to introduce this important resolution to raise awareness about AADC Deficiency in the public and medical community,” said Rep. Murphy. “Greater community awareness of this disease will aid patients who may be experiencing symptoms and help them pursue appropriate treatment. As a physician, I am honored to boost medical representation of AADC Deficiency in Congress and help educate the public about this rare disease.”
“It is imperative to spread awareness; not just to the community, but to physicians and specialists, so they can recognize the symptoms and give an early diagnosis,” said Kelly Heger, Director of the AADC Family Network.
Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency is a genetic neurologic rare disease that severely debilitates a patient’s development, motor skills, growth, and cognitive and language skills and limits a patient’s life. AADC Deficiency results from an inherited genetic disease where patients lack the AADC enzyme required to create dopamine and, without dopamine, patients will never achieve motor milestones, such as holding their heads up, sitting, and standing, or develop the ability to communicate or perform basic life functions. Patients suffering from AADC Deficiency often have unexplained low muscle tone and experience other symptoms like developmental delays and involuntary eye movements.